This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board Meeting on 16 Oct to Approve Q2 FY27 Results
HSCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Smallcap 250 and in line with its Chemicals & Petrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Himadri Speciality Chemical has informed BSE and NSE that its Board will meet on 16 October 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026. The trading window for insiders remains closed until 48 hours after results are declared.
Routine advance notice; investors should watch for the Q2 FY27 results announcement on or after 16 October 2026.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹1,691 Cr | ₹1,071 Cr | +57.9% |
| Operating profit | ₹265.5 Cr | ₹200.6 Cr | +32.4% |
| Profit after tax | ₹231.3 Cr | ₹176.1 Cr | +31.3% |
| EBITDA margin | 18.6% | 21.7% | −3.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.